“
TL;DR
Due to a ban on mercury sphygmomanometers, KNHANES will transition to using the Microlife oscillometric device for BP measurement and the Greenlight device as a reference for validation from 2023.
Clinical Hypertension · 13 authors, 13 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Due to a ban on mercury sphygmomanometers, KNHANES will transition to using the Microlife oscillometric device for BP measurement and the Greenlight device as a reference for validation from 2023.
Due to a ban on mercury sphygmomanometers, KNHANES will transition to using the Microlife oscillometric device for BP measurement and the Greenlight device as a reference for validation from 2023. The protocol aims to ensure accurate and reliable BP data for epidemiological research and public health policy.